Evidence map›Paper›PMID 40650078›Full record

ReviewInternational journal of molecular sciences2025

Homocysteine Attack on Vascular Endothelium-Old and New Features.

Loredana Liliana Hurjui, Cristina Claudia Tarniceriu, Dragomir Nicolae Serban, Ludmila Lozneanu, Gabriela Bordeianu, Alin Horatiu Nedelcu, Alin Constantin Panzariu, Raluca Jipu, Ruxandra Maria Hurjui, Daniela Maria Tanase and 1 more

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Loredana Liliana HurjuiDepartment of Morpho-Functional Sciences II, Physiology Discipline, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.ORCID 0000-0003-3803-9405
Cristina Claudia TarniceriuDepartment of Morpho-Functional Sciences I, Discipline of Anatomy, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
Dragomir Nicolae SerbanDepartment of Morpho-Functional Sciences II, Physiology Discipline, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
Ludmila LozneanuDepartment of Morpho-Functional Sciences I, Discipline of Histology, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.ORCID 0000-0002-3994-6579
Gabriela BordeianuDepartment of Morpho-Functional Sciences II, Biochemistry Discipline, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.ORCID 0000-0003-2947-2514
Alin Horatiu NedelcuDepartment of Morpho-Functional Sciences I, Discipline of Anatomy, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.ORCID 0000-0002-0024-0237
Alin Constantin PanzariuDepartment of Morpho-Functional Sciences II, Physiology Discipline, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.ORCID 0000-0001-5730-1662
Raluca JipuDepartment of Morpho-Functional Sciences II, Physiology Discipline, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
Ruxandra Maria HurjuiDepartment of Morpho-Functional Sciences I, Discipline of Histology, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
Daniela Maria TanaseDepartment of Internal Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 700111 Iasi, Romania.ORCID 0000-0002-7144-2506
Ionela Lacramioara SerbanDepartment of Morpho-Functional Sciences II, Physiology Discipline, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Homocysteine (Hcy) is becoming a well-established risk factor for cardiovascular disease (CVD), mainly involving endothelial dysfunction and atherogenesis. Endothelial dysfunction is reflected primarily in the complex regulation of the main physiological and pathophysiological processes. There is increasing evidence regarding abnormally high concentrations of plasma total homocysteine, or plasma hyperhomocysteinemia, contributing to endothelial dysfunction, inflammation, and CVD. This clinical and experimental study examined the connection between Hcy and cardiovascular disease risk. Homocysteine is a marker of total vascular damage that must be monitored and controlled as early as possible. Dietary and lifestyle changes are recommended for most patients with hyperhomocysteinemia (Hhcy). The purpose of this paper is to review the data from the specialized literature that demonstrate that there is a direct link between endothelial injury and increased homocysteine levels, identifying existing evidence, describing new mechanisms, and exploring potential new therapeutic options. These aspects continue to be debated, and additional efforts are required to refine therapeutic strategies and to investigate the potential implications of Hcy in health and disease.

Indexed as

Cardiovascular DiseasesEndothelium, VascularHomocysteineHyperhomocysteinemiaAnimalsAtherosclerosisBiomarkersHumansRisk FactorsBiomarkersHomocysteineendothelial dysfunctionhomocysteinehyperhomocysteinemia

Identifiers

PMID40650078
PMCPMC12249670

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.